SCHEMBL27129172

SCHEMBL27129172

Cc1cc(C(C)N)c2oc(-c3cnn(C(C)C)c3)c(C)c(=O)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.37
▸ WDR77 Q9BQA1 1/20 0.37
▸ PIK3CA P42336 3/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIP5K1C O60331 1/20 0.33
▸ PI4KA P42356 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ PI4KB Q9UBF8 1/20 0.33
▸ BMPR1A P36894 1/20 0.33
▸ ACVRL1 P37023 1/20 0.33
▸ ACVR1 Q04771 1/20 0.33
▸ KDM5B Q9UGL1 1/20 0.32
▸ AKT1 P31749 1/20 0.32
▸ AKT2 P31751 1/20 0.32
▸ AKT3 Q9Y243 1/20 0.32
▸ ALOX5AP P20292 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32
▸ PDE3B Q13370 2/20 0.32
▸ PDE3A Q14432 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26881834 1.00 PRMT5 (0.37) PRMT5WDR77PIK3CAPIK3CDPIP5K1C
SCHEMBL26881433 0.92 PDE3B (0.32) PRMT5WDR77PIK3CAAKT1AKT2
SCHEMBL27147951 0.92 PDE3B (0.32) PRMT5WDR77PIK3CAAKT1AKT2
SCHEMBL26881431 0.88 AURKA (0.35) PRMT5WDR77PIK3CAAKT1AKT2
SCHEMBL27009554 0.88 AURKA (0.35) PRMT5WDR77PIK3CAAKT1AKT2
SCHEMBL31481682 0.88 AURKA (0.35) PRMT5WDR77PIK3CAAKT1AKT2
SCHEMBL27008395 0.85 PIK3CA (0.33) PIK3CAAKT1AKT2AKT3CDK2
SCHEMBL27132366 0.85 PIK3CA (0.33) PIK3CAAKT1AKT2AKT3CDK2
SCHEMBL30742146 0.85 PIK3CA (0.33) PIK3CAAKT1AKT2AKT3CDK2
SCHEMBL26881835 0.83 MAP3K7 (0.37) PIK3CABMPR1AACVRL1ACVR1KDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE LOXO ONCOLOGY, INC. 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PIK3CA, PIK3R4, PIK3R5 PRMT5 1837/4885WDR77 2853/4885PIK3CA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback